Colonoscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Colonoscopes Pipeline Market Report Overview

A Colonoscope is a forward-viewing endoscope designed for examination of the entire colon and terminal ileum. A Colonoscope consists of a long and thin flexible tube having a miniature camera and light source at its distal end. The device consists of a tip housing, a flexible insertion tube, and a cord that connects the light source and the tip housing. The distal part of the insertion tube is flexible enough to allow the device to travel through the angulated areas of the colon.

The Colonoscopes market research report provides extensive coverage of the Colonoscopes under development. It reviews details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates. Additionally, the report reviews major players involved in the pipeline product development. It provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Colonoscopes pipeline products.

Key Territories ·       The US

·       Europe

·       Japan

·       South Korea

·       Israel

·       Taiwan

Key Segments ·       Flexible Non-Video (Fibre) Colonoscopes

·       Flexible Video Colonoscopes

Key Regulatory Paths ·       510(k)

·       CE

·       MDITAC

·       Ninsho

·       UKCA

·       BOPA

Leading Companies ·       Ambu A/S

·       ARTANN Laboratories Inc

·       Boston Medical Sciences Co Ltd

·       Consis Medical Inc

·       Dalin Tzu Chi General Hospital

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Colonoscopes Pipeline Market Segmentation by Categories

Flexible Video Colonoscopes. Flexible Non-Video (Fibre) Colonoscopes led the Colonoscopes market as of May 2024.

Flexible Non-Video (Fibre) Colonoscopes are fiberoptic instruments with a flexible bundle of glass fibres that collect the lighted image at one end and allow the colonoscopist to view the image through the eyepiece on the other end. One unit refers to one Flexible Non-Video (Fibre) Colonoscope.

Colonoscopes Pipeline Market Analysis by Categories, 2024 (%)

Colonoscopes Pipeline Market Analysis by Categories, 2024 (%)

Buy the Full Report for More Territory Insights into the Colonoscopes Pipeline Market

Download a Free Report Sample

Colonoscopes Pipeline Market Segmentation by Territories

A few of the key territories with the Colonoscopes pipeline market are the US, Europe, Japan, South Korea, Taiwan, and Israel. As of May 2024, the US accounted for the highest number of Colonoscope products.

Colonoscopes Pipeline Market Analysis by Territories, 2024 (%)

Colonoscopes Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Colonoscopes Pipeline Market

Download a Free Report Sample

Colonoscopes Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the Colonoscope pipeline market are 510(k), CE, MDITAC, Ninsho, UKCA, and BOPA. As of May 2024, 510(k) was the most followed pathway for pipeline products in the Colonoscopes market.

Colonoscope Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Colonoscope Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Colonoscopes Pipeline Market

Download a Free Report Sample

Colonoscopes Pipeline Market – Competitive Landscape

A few of the key companies associated with the Colonoscopes pipeline market are Ambu A/S, ARTANN Laboratories Inc., Boston Medical Sciences Co Ltd, Consis Medical Inc., and Dalin Tzu Chi General Hospital among others.

Ambu A/S (Ambu): Ambu A/S (Ambu) is a medical device company that manufactures and markets life-supporting devices. It focuses on single-use devices for anesthesia, endoscopy, cardiology, patient monitoring and diagnostics, and emergency care. It serves hospitals, clinics, sleep laboratories, and rescue services. The company’s product portfolio includes ventilation products for artificial respiration, resuscitators, single-use video scopes, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu sells its medical devices through a direct sales force and a network of distributors to hospitals and ambulances worldwide and operates offices in North America, Europe, and Asia-Pacific.

Colonoscopes Pipeline Market Analysis by Companies, 2024

Colonoscopes Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Colonoscopes Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Colonoscopes Market Territories Outlook (As of May 2024)

  • The US
  • Europe
  • Japan
  • South Korea
  • Israel
  • Taiwan

Colonoscopes Market Regulatory Paths Outlook (As of May 2024)

  • 510(k)
  • CE
  • MDITAC
  • Ninsho
  • UKCA
  • BOPA

Colonoscopes Pipeline Market Category Outlook (As of May 2024)

  • Flexible Non-Video (Fibre) Colonoscopes
  • Flexible Video Colonoscopes

Scope

This report provides:

  • Extensive coverage of the Colonoscopes under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Colonoscopes and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Colonoscopes under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Ambu A/S
ARTANN Laboratories Inc
Boston Medical Sciences Co Ltd
Consis Medical Inc
Dalin Tzu Chi General Hospital
Endoscape Inc (Inactive)
Ethicon Endo-Surgery Inc
Image In
Inmotion Medical Ltd
IQ Endoscopes Ltd
Kaleidoscope
Kitware Inc
Michigan State University
Microbot Medical Ltd
National University of Singapore
Novadaq Technologies Inc
Olympus Corp
Omniscient LLC
Precision Optics Corporation Inc
Saneso Inc
SpectraCyte LLC
Taewoong Medical Co Ltd
University of Maryland Baltimore
Xylo Technologies Ltd

Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Colonoscopes Overview 8

3 Products under Development 9

3.1 Colonoscopes – Pipeline Products by Stage of Development 9

3.2 Colonoscopes – Pipeline Products by Segment 10

3.3 Colonoscopes – Pipeline Products by Territory 11

3.4 Colonoscopes – Pipeline Products by Regulatory Path 12

3.5 Colonoscopes – Pipeline Products by Estimated Approval Date 13

3.6 Colonoscopes – Ongoing Clinical Trials 14

4 Colonoscopes – Pipeline Products under Development by Companies 15

4.1 Colonoscopes Companies – Pipeline Products by Stage of Development 15

4.2 Colonoscopes – Pipeline Products by Stage of Development 16

5 Colonoscopes Companies and Product Overview 17

5.1 Ambu A/S Company Overview 17

5.1.1 Ambu A/S Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 ARTANN Laboratories Inc Company Overview 18

5.2.1 ARTANN Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 Boston Medical Sciences Co Ltd Company Overview 19

5.3.1 Boston Medical Sciences Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Consis Medical Inc Company Overview 20

5.4.1 Consis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Dalin Tzu Chi General Hospital Company Overview 21

5.5.1 Dalin Tzu Chi General Hospital Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Endoscape Inc (Inactive) Company Overview 24

5.6.1 Endoscape Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

5.7 Ethicon Endo-Surgery Inc Company Overview 27

5.7.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Image In Company Overview 28

5.8.1 Image In Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Inmotion Medical Ltd Company Overview 29

5.9.1 Inmotion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 IQ Endoscopes Ltd Company Overview 30

5.10.1 IQ Endoscopes Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 Kaleidoscope Company Overview 31

5.11.1 Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 Kitware Inc Company Overview 32

5.12.1 Kitware Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 Michigan State University Company Overview 33

5.13.1 Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Microbot Medical Ltd Company Overview 34

5.14.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 National University of Singapore Company Overview 35

5.15.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 Novadaq Technologies Inc Company Overview 36

5.16.1 Novadaq Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.17 Olympus Corp Company Overview 37

5.17.1 Olympus Corp Pipeline Products & Ongoing Clinical Trials Overview 37

5.18 Omniscient LLC Company Overview 38

5.18.1 Omniscient LLC Pipeline Products & Ongoing Clinical Trials Overview 38

5.19 Precision Optics Corporation Inc Company Overview 39

5.19.1 Precision Optics Corporation Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.20 Saneso Inc Company Overview 40

5.20.1 Saneso Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.21 SpectraCyte LLC Company Overview 42

5.21.1 SpectraCyte LLC Pipeline Products & Ongoing Clinical Trials Overview 42

5.22 Taewoong Medical Co Ltd Company Overview 43

5.22.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.23 University of Maryland Baltimore Company Overview 44

5.23.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 44

5.24 Xylo Technologies Ltd Company Overview 45

5.24.1 Xylo Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

6 Colonoscopes- Recent Developments 46

6.1 Apr 25, 2024: Cosmo Announces Leadership Changes 46

6.2 Mar 04, 2024: Intelligent Scopes Launches Helga AI-GEP, an AI Platform for Gastroenterology With the Commencement of Validation of Its AI Software Tool for Colon Cancer 46

6.3 Feb 20, 2024: Cosmo Reports Excellent Preliminary Unaudited Full Year 2023 Core Financial Results – Record Guidance for 2024 – Doubles Dividend to € 2.00 Per Share 46

6.4 Jan 31, 2024: Stryker Corp Reports Strong Q4 and Full Year 2023 Results; Forecasts Continued Growth 49

6.5 Jan 28, 2024: Cosmo Artificial Intelligence Receives Additional 510(K) Clearance For GI Genius System 49

6.6 Jan 25, 2024: Cosmo Pharmaceuticals Announces Invitation to Investor Day and Full-Year 2023 Webcast – Zurich, 20 March 2024 49

6.7 Jan 25, 2024: New Study Shows SonarMD Drives 10X Reduction in Hospital Admissions and Emergency Visits Related to IBD 51

6.8 Dec 11, 2023: Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care 52

6.9 Dec 06, 2023: Cosmo Confirms Full Redemption in Cash of €175m Convertible Bonds 53

6.10 Nov 13, 2023: Olympus Corp Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2024 53

6.11 Oct 09, 2023: Stryker to Host Investor Day 53

6.12 Oct 03, 2023: Olympus Names Dr. John de Csepel as Chief Medical Officer 54

6.13 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023 54

6.14 Sep 25, 2023: Fujifilm Receives 510(k) Clearance for Endoscope Model EC-760S-A/L 54

6.15 Sep 25, 2023: Fujifilm Receives 510(k) Clearance for EW10-VM01 Software 55

6.16 Sep 05, 2023: GI-View Receives Additional 510(k) Clearance for the Aer-O-Scope 55

6.17 Aug 17, 2023: Kips Bay Endoscopy Center Now Incorporates Artificial Intelligence System for Enhanced Colonoscopy Screenings in New York City 55

6.18 Aug 10, 2023: Pentax of America Receives 510(k) Clearance for PENTAX Medical Video Colonoscope EC38-i20cL 56

6.19 Jun 05, 2023: Prestigious NHS AI award paves way for real-world trial of GI Genius intelligent endoscopy module 56

6.20 Jun 04, 2023: Cosmo Pharmaceuticals receives additional 510(k) clearance for the GI Genius 57

7 Appendix 58

7.1 Methodology 58

7.2 About GlobalData 61

7.3 Contact Us 61

7.4 Disclaimer 61

Table

Colonoscopes – Pipeline Products by Stage of Development 9

Colonoscopes – Pipeline Products by Segment 10

Colonoscopes – Pipeline Products by Territory 11

Colonoscopes – Pipeline Products by Regulatory Path 12

Colonoscopes – Pipeline Products by Estimated Approval Date 13

Colonoscopes – Ongoing Clinical Trials 14

Colonoscopes Companies – Pipeline Products by Stage of Development 15

Colonoscopes – Pipeline Products by Stage of Development 16

Ambu A/S Pipeline Products & Ongoing Clinical Trials Overview 17

Colonoscope – Product Status 17

Colonoscope – Product Description 17

ARTANN Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Colonoscopy Force Monitor – Product Status 18

Colonoscopy Force Monitor – Product Description 18

Boston Medical Sciences Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

AIM4CRC – Product Status 19

AIM4CRC – Product Description 19

Consis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Self-Propelled Endoscope – Product Status 20

Self-Propelled Endoscope – Product Description 20

Dalin Tzu Chi General Hospital Pipeline Products & Ongoing Clinical Trials Overview 21

Real-Time Computer-Aided Colon Polyp Detection System – Product Status 21

Real-Time Computer-Aided Colon Polyp Detection System – Product Description 21

Dalin Tzu Chi General Hospital – Ongoing Clinical Trials Overview 22

Real-Time Computer-Aided Colon Polyp Detection System – Adenoma Detection Using Real-Time Computer-Aided Colon Polyp Detection System to Compare Water Exchange and Air Insufflation – A Randomized Controlled Trial 23

Endoscape Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

Advanced Angulation Control System – Product Status 24

Advanced Angulation Control System – Product Description 24

Colon Grasping Device – Product Status 25

Colon Grasping Device – Product Description 25

Colon Intubation Assist Device – Product Status 25

Colon Intubation Assist Device – Product Description 26

Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Colonoscope – Product Status 27

Colonoscope – Product Description 27

Image In Pipeline Products & Ongoing Clinical Trials Overview 28

Disposable Colonoscope – Product Status 28

Disposable Colonoscope – Product Description 28

Inmotion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Disposable Colonoscopic Device – Product Status 29

Disposable Colonoscopic Device – Product Description 29

IQ Endoscopes Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Colonoscope – Product Status 30

Colonoscope – Product Description 30

Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview 31

Infrared Colonoscope – Product Status 31

Infrared Colonoscope – Product Description 31

Kitware Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Automatic Detection System – Colonoscopy – Product Status 32

Automatic Detection System – Colonoscopy – Product Description 32

Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 33

Raman Endoscope Device – Colon Cancer – Product Status 33

Raman Endoscope Device – Colon Cancer – Product Description 33

Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

TipCat – Semi – Disposable Endoscope – Product Status 34

TipCat – Semi – Disposable Endoscope – Product Description 34

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 35

Naviscope – Product Status 35

Naviscope – Product Description 35

Novadaq Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Onco-LIFE Autofluorescence – Colon – Product Status 36

Onco-LIFE Autofluorescence – Colon – Product Description 36

Olympus Corp Pipeline Products & Ongoing Clinical Trials Overview 37

Ultrawide Angle Colonoscope – Product Status 37

Ultrawide Angle Colonoscope – Product Description 37

Omniscient LLC Pipeline Products & Ongoing Clinical Trials Overview 38

Dual-View Endoscope – Product Status 38

Dual-View Endoscope – Product Description 38

Precision Optics Corporation Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Multi Camera Colonoscope – Product Status 39

Multi Camera Colonoscope – Product Description 39

Saneso Inc Pipeline Products & Ongoing Clinical Trials Overview 40

SCA 360: Saneso 360 Colonoscope Adult – Product Status 40

SCA 360: Saneso 360 Colonoscope Adult – Product Description 40

SCP 360: Saneso 360 Colonoscope Pediatric – Product Status 41

SCP 360: Saneso 360 Colonoscope Pediatric – Product Description 41

SpectraCyte LLC Pipeline Products & Ongoing Clinical Trials Overview 42

Next-Generation Gastrointestinal Endoscope – Product Status 42

Next-Generation Gastrointestinal Endoscope – Product Description 42

Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

Colonoscope – Product Status 43

Colonoscope – Product Description 43

University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 44

Manometry Monitoring Device – Product Status 44

Manometry Monitoring Device – Product Description 44

Xylo Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

Fluorescent Colonoscope – Product Status 45

Fluorescent Colonoscope – Product Description 45

Glossary 60

Figures

Colonoscopes – Pipeline Products by Stage of Development 9

Colonoscopes – Pipeline Products by Segment 10

Colonoscopes – Pipeline Products by Territory 11

Colonoscopes – Pipeline Products by Regulatory Path 12

Colonoscopes – Pipeline Products by Estimated Approval Date 13

Colonoscopes – Ongoing Clinical Trials 14

Frequently asked questions

Colonoscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Colonoscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Colonoscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Colonoscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.